Rtw Investments as of Dec. 31, 2018
Portfolio Holdings for Rtw Investments
Rtw Investments holds 46 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 22.0 | $236M | 16M | 14.71 | |
| Arrowhead Pharmaceuticals (ARWR) | 6.2 | $66M | 5.3M | 12.42 | |
| Ptc Therapeutics I (PTCT) | 6.1 | $66M | 1.9M | 34.32 | |
| Dicerna Pharmaceuticals | 5.9 | $63M | 5.9M | 10.69 | |
| Bristol Myers Squibb (BMY) | 4.6 | $49M | 951k | 51.98 | |
| Regenxbio Inc equity us cm (RGNX) | 4.1 | $44M | 1.1M | 41.95 | |
| Livanova Plc Ord (LIVN) | 3.8 | $41M | 443k | 91.47 | |
| Sarepta Therapeutics (SRPT) | 3.7 | $40M | 366k | 109.13 | |
| Vericel (VCEL) | 3.7 | $40M | 2.3M | 17.40 | |
| Masimo Corporation (MASI) | 3.4 | $37M | 342k | 107.37 | |
| Homology Medicines | 3.4 | $37M | 1.6M | 22.36 | |
| Alnylam Pharmaceuticals (ALNY) | 3.0 | $32M | 440k | 72.91 | |
| Agenus | 2.2 | $24M | 10M | 2.38 | |
| Establishment Labs Holdings Ord (ESTA) | 2.1 | $23M | 848k | 26.81 | |
| Achillion Pharmaceuticals | 2.0 | $22M | 14M | 1.59 | |
| Adverum Biotechnologies | 1.8 | $20M | 6.3M | 3.15 | |
| Si-bone (SIBN) | 1.6 | $17M | 804k | 20.89 | |
| Arbutus Biopharma (ABUS) | 1.6 | $17M | 4.3M | 3.83 | |
| Axonics Modulation Technolog (AXNX) | 1.5 | $17M | 1.1M | 15.11 | |
| Sage Therapeutics (SAGE) | 1.5 | $16M | 166k | 95.79 | |
| Assembly Biosciences | 1.4 | $16M | 687k | 22.62 | |
| Myokardia | 1.3 | $14M | 295k | 48.86 | |
| Principia Biopharma | 1.3 | $14M | 556k | 25.47 | |
| Cytomx Therapeutics (CTMX) | 1.3 | $14M | 909k | 15.10 | |
| Uniqure Nv (QURE) | 1.2 | $13M | 462k | 28.82 | |
| Johnson & Johnson (JNJ) | 1.0 | $10M | 81k | 129.05 | |
| Concert Pharmaceuticals I equity | 0.9 | $9.9M | 789k | 12.55 | |
| Caredx (CDNA) | 0.8 | $8.2M | 328k | 25.14 | |
| Viewray (VRAYQ) | 0.8 | $8.3M | 1.4M | 6.07 | |
| Orthopediatrics Corp. (KIDS) | 0.7 | $7.8M | 225k | 34.88 | |
| D Fluidigm Corp Del (LAB) | 0.7 | $7.6M | 884k | 8.62 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.7 | $7.1M | 448k | 15.78 | |
| Chardan Healthcare Acquisition | 0.6 | $6.0M | 600k | 10.07 | |
| Viveve Med | 0.4 | $4.7M | 4.5M | 1.05 | |
| Odonate Therapeutics Ord | 0.4 | $4.4M | 312k | 14.08 | |
| Solid Biosciences | 0.3 | $3.6M | 134k | 26.80 | |
| Vivus Inc conv | 0.3 | $3.2M | 4.0M | 0.81 | |
| Neuronetics (STIM) | 0.3 | $3.2M | 168k | 19.35 | |
| Electrocore | 0.3 | $3.2M | 518k | 6.26 | |
| Argenx Se (ARGX) | 0.3 | $2.8M | 29k | 96.08 | |
| La Jolla Pharmaceuticl Com Par | 0.2 | $2.5M | 268k | 9.43 | |
| Mirati Therapeutics | 0.1 | $1.6M | 39k | 42.41 | |
| Motus Gi Hldgs Incorporated | 0.1 | $1.4M | 460k | 3.11 | |
| Proteostasis Therapeutics In | 0.1 | $1.0M | 314k | 3.24 | |
| Optinose (OPTN) | 0.1 | $493k | 80k | 6.20 | |
| Ra Med Sys | 0.1 | $487k | 61k | 7.95 |
